- You need to sign in or sign up before continuing.
0
0
3/5/26 at 5:00am
Organization
FDA.gov
Author
Office of the Commissioner
50 words
0
Comments
The U.S. Food and Drug Administration today approved teclistamab in combination with daratumumab hyaluronidase-fihj, Tec-Dara, to treat adult patients with relapsed or refractory multiple myeloma who have received at least one prior line of therapy.
You are the first to view
https://www.fda.gov/news-events/press-announcements/fda-grants-third-approval-under-national-priority-voucher-program
Create an account
or login to join the discussion